2026 NPPES data Hematology & Oncology Physician NPI 1679550842 M.D.
Verify on CMS →

KATHY ALBAIN, M.D.

Hematology & Oncology Physician in MAYWOOD, Illinois. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
460
Medicare Part D claims · 94 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
87%
generic claims · 13% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: KATHY ALBAIN, M.D. is a Hematology & Oncology Physician ([object Object]) practicing in MAYWOOD, Illinois with a Medicare Part D prescribing footprint of 460 claims across 94 beneficiaries — 13% brand-name prescribing .

What stands out: KATHY ALBAIN, M.D. filed 460 Medicare Part D claims in 2023 across MAYWOOD, Illinois. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

KATHY ALBAIN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

KATHY ALBAIN, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 12/28/2005

NPI 1679550842

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

460 46% vs specialty avg

2023 prescription claims

Specialty avg: 847

Specialty distribution in Illinois

How Hematology & Oncology Physician compares to other specialties among Illinois providers

Illinois providers

Hematology & Oncology Physician share within Illinois

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Illinois

Specialty board-certification context

Estimated specialty board-certified rate — Hematology & Oncology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Hematology & Oncology Physician ABMS/AOA estimate

Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Hematology & Oncology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KATHY ALBAIN, M.D. is a Hematology & Oncology Physician provider practicing in MAYWOOD, Illinois, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1679550842. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

KATHY ALBAIN, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 2160 S FIRST AVE, MAYWOOD, IL, 60153, with a listed phone of (708) 216-9000. NPI 1679550842 was issued on 12/28/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ALBAIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 460 prescription claims written by this provider, covering 94 Medicare beneficiaries and totaling roughly $500K in drug spend, split 13% brand-name and 87% generic by claim count, with an opioid prescribing rate of 7.0%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

2160 S FIRST AVE
MAYWOOD, IL 60153

Provider Details

NPI 1679550842
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 12/28/2005

Hospital and facility affiliations

Facilities where KATHY ALBAIN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

LOYOLA UNIVERSITY MEDICAL CENTER
★★☆☆☆ 2/5
MAYWOOD, IL
Acute Care Hospitals
CMS CCN: 140276

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Illinois IDFPR 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~42K Illinois medical licensees in 2023 — they are NOT specific to KATHY ALBAIN, M.D.. To verify KATHY ALBAIN, M.D.'s current license status, search the IDFPR public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

106
Total board actions, Illinois 2023
Across 103 cases
2.52
Actions per 1,000 licensees
Illinois statewide rate
probation
Most common action type
38 cases

IDFPR publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Illinois disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

KATHY ALBAIN, M.D. — brand share 13.0%
Specialty average (est.)

13% brand-name claims vs 87% generic, on 460 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

460
Total Claims
$500K
Total Drug Cost
94
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
887
Total Day Supply
23,938
Brand vs Generic
13% brand / 87% generic
Brand Drug Cost
$476K
Generic Drug Cost
$24K
Opioid Claims
32 (7.0% rate)

Patient Demographics

Average Patient Age
74.1 years
Avg HCC Risk Score
1.79

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Letrozole
111
Exemestane
87
Ondansetron Hcl
38
Anastrozole
33
Dexamethasone
28
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
26
Prochlorperazine Maleate
21
Tamoxifen Citrate
18
Ibrance
Palbociclib
12
Tagrisso
Osimertinib Mesylate
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How KATHY ALBAIN, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

KATHY ALBAIN, M.D.'s 460 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Illinois

Other clinicians with the same primary specialty enrolled in Illinois, drawn from the same CMS NPPES roster as ALBAIN.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KATHY ALBAIN, M.D.'s specialty?
KATHY ALBAIN, M.D. specializes in Hematology & Oncology Physician and practices in MAYWOOD, Illinois. Credentials: M.D..
How much does KATHY ALBAIN, M.D. prescribe under Medicare Part D?
In 2023, KATHY ALBAIN, M.D. wrote 460 Medicare Part D claims totaling $500K in drug costs for 94 beneficiaries.
Where is KATHY ALBAIN, M.D. located?
KATHY ALBAIN, M.D. is located at 2160 S FIRST AVE, MAYWOOD, IL, 60153. Phone: (708) 216-9000.
What is KATHY ALBAIN, M.D.'s NPI number?
KATHY ALBAIN, M.D.'s National Provider Identifier (NPI) is 1679550842, issued on 12/28/2005.
Does KATHY ALBAIN, M.D. prescribe more brand-name or generic drugs?
KATHY ALBAIN, M.D.'s prescribing is 13% brand-name and 87% generic drugs by claim count, with $476K in brand drug costs.
Does KATHY ALBAIN, M.D. prescribe opioids?
Yes, KATHY ALBAIN, M.D. had 32 opioid claims in 2023 with an opioid prescribing rate of 7.0%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does KATHY ALBAIN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, KATHY ALBAIN, M.D.'s most frequently prescribed drugs include Letrozole, Exemestane, Ondansetron Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KATHY ALBAIN, M.D. accept Medicare?
KATHY ALBAIN, M.D. appears in CMS Medicare data with 460 Part D claims and 94 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KATHY ALBAIN, M.D.'s credentials?
KATHY ALBAIN, M.D.'s NPI is 1679550842 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology